The following section discusses management's views of the consolidated financial
condition and the results of operations and cash flows of Sharing Services
Global Corporation and subsidiaries. This section should be read in conjunction
with: (a) our audited consolidated financial statements and related notes
included in our Annual Report on Form 10-K for the fiscal year ended March 31,
2022, and (b) our unaudited condensed consolidated financial statements included
elsewhere in this Quarterly Report. This section may contain forward-looking
statements. See "Cautionary Notice Regarding Forward-Looking Statements" above
for a discussion of forward-looking statements.



Summary Results of Operations:




                                          Three Months Ended                                                              Nine Months Ended
                                        December 31,        Increase                                                                           Increase
                 December 31, 2022          2021           (Decrease)        % Change        December 31, 2022       December 30, 2021        (Decrease)        % Change
Net sales       $         3,245,903     $   7,110,532        (3,864,629 )         -54.4 %   $        12,737,673     $        28,195,359     $  (15,457,686 )         -54.8 %
Gross profit              1,602,792         4,781,949        (3,179,157 )         -66.5 %             7,677,757              19,588,526        (11,910,769 )         -60.8 %
Operating
expenses                 (5,606,866 )      (7,831,883 )       2,225,017           -28.4 %           (19,511,086 )           (28,273,529 )        8,762,443           -31.0 %
Operating
loss                     (4,004,074 )      (3,049,934 )        (954,140 )          31.3 %           (11,833,329 )            (8,685,003 )       (3,148,326 )          36.3 %
Non-Operating
(expense),
net                      (6,916,748 )      (2,065,155 )      (4,851,593 )         234.9 %           (19,720,337 )            (3,199,103 )      (16,521,234 )         516.4 %
Loss before
income taxes            (10,920,822 )      (5,115,089 )      (5,805,733 )         113.5 %           (31,553,666 )           (11,884,106 )      (19,669,560 )         165.5 %
Income tax
(benefit)
expense                     104,129         1,825,073        (1,720,944 )         -94.3 %              (789,803 )             1,318,827         (2,108,630 )        -159.9 %
Net loss        $       (11,024,951 )   $  (6,940,162 )   $  (4,084,789 )          58.9 %   $       (30,763,863 )   $       (13,202,933 )   $  (17,560,930 )         133.0 %



Highlights for the Three Months Ended December 31, 2022:

? For the three months ended December 31, 2022, our consolidated net sales

decreased $3.9 million, or 54.4%, to $3.2 million, compared to the three

months ended December 31, 2021.

? For the three months ended December 31, 2022, our consolidated gross profit

decreased $3.2 million, or 66.5%, to $1.6 million, compared to the three

months ended December 31, 2021. Our consolidated gross margin was 49.4% for

the three months ended December 31, 2022, compared to 67.3% for the three

months ended December 31, 2021.

? For the three months ended December 31, 2022, our consolidated operating

expenses decreased $2.2 million, or 28.4%, to $5.6 million, compared to the

three months ended December 31, 2021.

? For the three months ended December 31, 2022, our consolidated operating loss

was $4.0 million, compared to $3.0 million for the three months ended December

31, 2021.

? For the three months ended December 31, 2022, our consolidated net

non-operating expense was $6.9 million, compared to net non-operating expenses

of $2.1 million for the three months ended December 31, 2021.

? For the three months ended December 31, 2022, our consolidated net loss was

$11.0 million compared to net loss of $6.9 million for the three months ended

December 31, 2021. For the three months ended December 31, 2022, and December

31, 2021, our diluted losses per share were $0.04 and $0.04, respectively.

? For the nine months ended December 31, 2022, our consolidated net cash used by

operating activities was $8.9 million compared to $13.2 million for the nine

months ended December 31, 2021.

? In June 2022, the Company and Decentralized Sharing Systems, Inc. ("DSSI"), a

subsidiary of DSS, Inc. ("DSS"), and, together with DSS, a major shareholder

of the Company entered into an agreement pursuant to which the parties to the

agreement replaced the $30.0 million loan from April 2021 with a $27.0 million

loan.

? In June 2022, the Company, through a subsidiary, and American Pacific Bancorp,

Inc. ("APB"), a subsidiary of DSS, entered into a Loan Agreement pursuant to

which APB loaned the Company approximately $5.7 million.

? In August 2022, the Company entered into a revolving credit promissory note

("the Note") with APB, pursuant to which the Company has access to advances

with a maximum principal balance, not to exceed the principal sum of $10.0

million. In December 2022, APB and the Company mutually agreed to limit and/or

end any further commitment by APB to fund or to readvance under the terms of


    the Note.




25







Overview



Summary Description of Business

Sharing Services Global Corporation and subsidiaries ("Sharing Services", "we,"
or the "Company") aim to build shareholder value by developing or acquiring
businesses and technologies that increase the Company's product and services
portfolio, business competencies, and geographic reach. Sharing Services'
combined platform leverages the capabilities and expertise of various companies
that market and sell products direct to the consumer through independent
contractors. The Company's new shared service platform will service this direct
selling "gig economy" sector by providing needed services (such as equity and
inventory financing, advisory services, mobile application tools, merchant
processing services, commercial insurance, and event planning) to smaller direct
sales companies initially in the U.S.



Currently, the Company, through its subsidiaries, markets and distributes its
health and wellness and other products primarily in the U.S. and Canada using a
direct selling business model. The Company's U.S. subsidiaries market our
products and services through an independent sales force, using their
proprietary websites, including: www.elevacity.com and www.thehappyco.com. In
September 2021, the Company, through a subsidiary, commenced operations in the
Republic of Korea (South Korea).



The Company was incorporated in the State of Nevada on April 24, 2015.





As further discussed below, the Company intends to continue to grow its business
both organically and by making strategic acquisitions from time to time of
businesses and technologies that augment its product portfolio, complement its
business competencies, and fit its growth strategy.



Convertible Notes and Borrowing Under Short-term Financing Arrangements


Historically, the Company has funded a substantial portion of its liquidity and
cash needs through the intermittent issuance of convertible notes and borrowings
under short-term financing arrangements, and through the intermittent issuance
of equity securities. See "Liquidity and Capital Resources" below for additional
information about the Company's convertible notes and borrowings under
short-term financing arrangements.



Industry and Business Trends


The information in "Industry and Business Trends" included in ITEM 1 - "Business" in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022, is incorporated herein by reference.

Strategic Profitable Growth Initiatives





The Company intends to continue to grow its business by pursuing a multipronged
growth strategy, that includes: (a) expanding its product offerings, both within
the health and wellness category and in new product categories, (b) expanding
its direct-to-consumer geographic footprint (primarily in Asia), and (c)
expanding its membership-based consumer travel products line in the U.S. and
worldwide. This growth strategy may also include the use of strategic
acquisitions of businesses that augment the Company's product and services
portfolio, business competencies and geographic reach.



Continuing Uncertainty Regarding the Recent COVID-19 Pandemic


In 2020, in response to the COVID-19 pandemic, governments in the countries
where our products are sold mandated or recommended various containment
measures, including selective business closures, social distancing, quarantine,
stay-at-home or shelter-in-place directives, and limitations on, or
cancellations of, larger meetings and other public events. We believe that the
actual impact of the health crisis, and/or actions taken to contain the spread
of the virus, have had and continue to have an adverse impact on the economies
in the geographies we serve. Consumer demand for discretionary products such as
ours is sensitive to significant downturns in the economy, increases in
unemployment or decreases in perceived employment security, and decreases in
consumer sentiment in general.



In efforts to protect our customers, distributors, employees, and other business
partners, in 2020, we instituted several preventive measures, including
temporarily transitioning a significant number of our corporate employees to
working remotely, increasing efforts to clean and sanitize our business
facilities, increasing employee safety communication, and transitioning our
sales conventions to a virtual convention platform. While these temporary
measures are increasingly being eased or fully reversed at the time of this
Quarterly Report, we believe these necessary, temporary measurements are likely
to have had an adverse impact on our business.



26







As a result of the foregoing, we cannot predict with certainty the scope,
duration, and ultimate impact of this public health emergency in the countries
where we operate, including its impact on the economy, but we believe these
conditions are likely to have had and continue to have a material adverse impact
on our business, financial condition, cash flows, and results of operations
(including revenues and profitability), and those of our key suppliers.



The COVID-19 pandemic also may have the effect of exacerbating some of the other
risk factors described elsewhere in our Annual Report on Form 10-K for the
fiscal year ended March 31, 2022, including the success of our growth
initiatives, our ability to anticipate and effectively respond to changes in
consumer preferences and buying trends in a timely manner, our dependence on one
supplier for a substantial portion of the products we sell, potential
fluctuations in our quarterly financial performance, our ability to generate
sustained, positive cash flows from operations with which to fund our working
capital needs, the potential impact on our financial performance from economic
slowdowns, our ability to effectively and cost-efficiently respond to any
epidemics and other health emergencies, and the potential impact on our business
of any disruption in our information technology systems.



Results of Operations


Three months ended December 31, 2022, Compared to Three months ended December 31, 2021

Net Sales



For the three months ended December 31, 2022, our consolidated net sales
decreased by $3.9 million, or 54.4%, to $3.2 million, compared to the three
months ended December 31, 2021. The decrease in net sales mainly reflects: (a)
continuation of the decline in consumer orders that we experienced since the
fourth quarter of the fiscal year 2020, (b) a decline in independent distributor
orders, in the number of new independent distributors and in the number of
continuing active distributors, resulting, in part, from recent product
reformulations and increased competition for independent distributors, and (c)
the generally adverse impact on consumer buying trends resulting from the recent
increase in consumer good prices and in energy costs in the U.S. and from
lingering effects of the COVID global health emergency and actions taken to help
mitigate the spread of the virus in the geographies in which we operate. In
efforts to restore strong sales growth, in the past several months, we have
developed and launched our new business brand, "The Happy CoTM," at our
Elevacity division, have accelerated our previously announced initiatives to
expand our operations into additional international geographies, and have
further intensified our efforts to recruit, develop and reward our distributors
and our efforts to reach new consumers, including through the continued
introduction of new products.



We believe there continues to be significant uncertainty about the potentially
adverse impact of the current health crisis on the economies and employment
markets of several countries, including the U.S. and Canada. Please see Overview
- Significant Uncertainty Regarding the Potential Impact of Ongoing COVID Health
Crisis above.


The $3.9 million decrease in consolidated net sales primarily reflects a decrease in number of comparable product units sold, partially offset by sales of products introduced since December 31, 2021, of approximately $1.2 million.





During the three months ended December 31, 2022, and 2021, the Company derived
substantially all its consolidated net sales from the sale of its Elevate health
and wellness product line.



During the nine months ended December 31, 2022, approximately 63% of the
Company's net sales were to customers (including 39% to recurring customers,
refer herein as "SmartShip" sales, and approximately 24% to new customers) and
approximately 37% of the Company's net sales were to independent distributors.



Gross Profit



For the three months ended December 31, 2022, our consolidated gross profit
decreased by $3.2 million, or 66.5%, to $1.6 million, compared to the three
months ended December 31, 2021, and our consolidated gross margins were 49.4%
and 67.3%, respectively. For the three months ended December 31, 2022, gross
margin was affected by an increase in shipping expenses and promotional pricing,
as a percentage of sales.


Selling and Marketing Expenses


For the three months ended December 31, 2022, our consolidated selling and
marketing expenses decreased by $3.3 million, to $0.9 million, or 28.6% of net
sales compared to $4.2 million, or 59.3% of net sales for the three months ended
December 31, 2021. The decrease in consolidated selling and marketing expenses
is due primarily to lower sales commissions of $2.6 million (which reflects
decrease in our consolidated net sales discussed above).



27






General and Administrative Expenses


For the three months ended December 31, 2022, our consolidated general and
administrative expenses (which include corporate employee compensation and
benefits, stock-based compensation, professional fees, rent and other occupancy
costs, certain consulting fees, telephone and information technology expenses,
insurance premiums, and other administrative expenses) increased by
approximately $1.1 to $4.7 million, or 144.1% of consolidated net sales compared
to $3.6 million, or 50.8% of consolidated net sales, for the three months ended
December 31 , 2021. The increase in consolidated general and administrative
expenses was primarily driven by higher consulting expenses offset by a decrease
in employee compensation and benefits and legal expenses.



Interest Expense, net



For the three months ended December 31, 2022, our consolidated interest expense,
net was 3.3 million, including amortization of debt discount and deferred
financing costs, interest income, and other expenses associated with borrowings
from "DSSI" and related parties.



For the three months ended December 31, 2021, our consolidated interest expense
was $3.1 including amortization of debt discount and deferred financing costs,
interest income, and other expenses associated with borrowings from "DSSI"

and
related parties.


Net Other Non-Operating Expenses





For the three months ended December 31, 2022, we had net consolidated
non-operating expenses of approximately $6.9 million. For the three months ended
December 31, 2021, our consolidated non-operating income was approximately
$2.1
million.


Unrealized Gain (Loss) on Investments in Unconsolidated Entities and Marketable Securities

For the three months ended December 31, 2022, net unrealized losses, before income tax, in connection with our investments in unconsolidated entities and marketable securities were $3.6 million.

For the three months ended December 31, 2021, net unrealized gains, before income tax, in connection with our investment in unconsolidated entities were $1.2 million.

Gain on Employee Warrants Liability


For the three months ended December 31, 2022, we recognized a compensatory gain
of $39,375, compared to $154,488 for the three months ended December 31, 2021,
in connection with employee warrants with a variable exercise price after
service was completed.



Income Tax Benefit


Income tax benefit includes current and deferred income taxes for both our domestic and foreign operations. Income from our international operations is subject to taxation in the countries in which we operate.





During the three months ended December 31, 2022, the Company had a state and
local tax benefit of $22,849 and a provision for deferred federal income taxes
of $348,236 and a benefit for current federal income taxes of $429,516.



Net Loss and Loss per Share



As a result of the foregoing, for the three months ended December 31, 2022, our
consolidated net loss was $11.0 million, compared to $6.9 million for the three
months ended December 31, 2021. For the three months ended December 31, 2022,
and December 31, 2021, our diluted loss per share was $0.04 and $0.04,
respectively.



28






Nine months ended December 31, 2022, Compared to the Nine months ended December 31, 2021

Net Sales



For the nine months ended December 31, 2022, our consolidated net sales
decreased by $15.5 million, or 54.8%, to $12.7 million, compared to the nine
months ended December 31, 2021. The decrease in net sales mainly reflects: (a)
continuation of the decline in consumer orders that we experienced since the
fourth quarter of the fiscal year 2020, (b) a decline in independent distributor
orders, in the number of new independent distributors and in the number of
continuing active distributors, resulting, in part, from recent product
reformulations and increased competition for independent distributors, and (c)
the generally adverse impact on consumer buying trends resulting from the recent
increase in consumer good prices and in energy costs in the U.S. and from
lingering effects of the COVID global health emergency and actions taken to help
mitigate the spread of the virus in the geographies in which we operate. In
efforts to restore strong sales growth, in the past several months, we have
developed and launched our new business brand, "The Happy CoTM," at our
Elevacity division, have accelerated our previously announced initiatives to
expand our operations into additional international geographies, and have
further intensified our efforts to recruit, develop and reward our distributors
and our efforts to reach new consumers, including through the continued
introduction of new products.



We believe there continues to be significant uncertainty about the potentially
adverse impact of the current health crisis on the economies and employment
markets of several countries, including the U.S. and Canada. Please see Overview
- Significant Uncertainty Regarding the Potential Impact of Ongoing COVID Health
Crisis above.


The $15.5 million decrease in consolidated net sales primarily reflects a decrease in the number of comparable product units sold, partially offset by sales of products introduced since December 31, 2021, of approximately $800,000.





During the nine months ended December 31, 2022, and 2021, the Company derived
substantially all its consolidated net sales from the sale of its Elevate health
and wellness product line.



During the nine months ended December 31, 2022, approximately 63% of the
Company's net sales were to customers (including 39% to recurring customers,
refer herein as "SmartShip" sales, and approximately 24% to new customers) and
approximately 37% of the Company's net sales were to independent distributors.



Gross Profit


For the nine months ended December 31, 2022, our consolidated gross profit decreased by $11.9 million, or 60.8%, to $7.7 million, compared to the nine months ended December 31, 2021, and our consolidated gross margins were 60.3% and 69.5%, respectively. For the nine months ended December 31, 2022, gross margin was affected by shipping expenses and promotional pricing, as a percentage of sales.

Selling and Marketing Expenses





For the nine months ended December 31, 2022, our consolidated selling and
marketing expenses decreased by $8.7 million, to $5.7 million, or 44.9% of net
sales compared to $14.4 million, or 51.0% of net sales for the nine months ended
December 31, 2021. The decrease in consolidated selling and marketing expenses
is due primarily to lower sales commissions of $8.6 million (which reflects
decrease in our consolidated net sales discussed above) partially offset by
higher sales convention expenses of approximately $454,465 (as we resumed
holding some in-person conventions).



General and Administrative Expenses





For the nine months ended December 31, 2022, our consolidated general and
administrative expenses (which include corporate employee compensation and
benefits, stock-based compensation, professional fees, rent and other occupancy
costs, certain consulting fees, telephone and information technology expenses,
insurance premiums, and other administrative expenses) decreased by
approximately $94,370 to $13.8 million, or 108.2% of consolidated net sales
compared to $13.9 million, or 49.2% of consolidated net sales, for the nine
months ended December 31 , 2021. The decrease in consolidated general and
administrative expenses was primarily driven by lower professional fees,
employee compensation and benefits and legal expenses.



Interest Expense, net



For the nine months ended December 31, 2022, our consolidated interest expense
was $9.8 million, including amortization of debt discount and deferred financing
costs, interest income, and other expenses associated with borrowings from

"DSSI" and related parties.



29







For the nine months ended December 31, 2021, consolidated interest expense was
$9.2 million, including amortization of debt discount and deferred financing
cost, interest income, and other expenses associated with borrowings from "DSSI"
and related parties.


Other Non-operating Income/Expenses

For the nine months ended December 31, 2022, our net consolidated non-operating income, includes litigation settlements and other non-operating income of $133,199. For the nine months ended December 31, 2021, consolidated other non-operating expenses (including litigation settlements) were $59,516.

Gain on employee warrants liability





For the nine months ended December 31, 2022, we recognized a compensatory gain
of $207,210, compared to $1.9 million for the nine months ended December 31,
2021, in connection with employee warrants with a variable exercise price after
service was completed.


Gain on Extinguishment of Debt





For the nine-month ended December 31, 2022, no amounts were incurred related to
extinguishment of debt. In June of 2021, the Company's borrowings under the
Paycheck Protection Program features of the Coronavirus Aid, Relief, and
Economic Security Act of 2020 (the "CARES Act") were forgiven pursuant to the
CARES Act. The Company recognized a gain on extinguishment of debt of $1.0
million, before income tax, in connection therewith.



Income Tax Benefit


During the nine months ended December 31, 2022, the Company recognized a provision for deferred taxes and federal taxes of $799,748 and a state and local tax benefit of $9,945.





During the nine months ended December 31, 2021, the Company recognized a
consolidated provision for current federal income taxes of $5.2 million, net of
a valuation allowance recognized of $4.5 million, and a consolidated provision
for state and local taxes of $109,241 and a consolidated deferred income tax
benefit of $4.0 million.



Net Loss and Loss per Share


As a result of the foregoing, for the nine months ended December 31, 2022, our
consolidated net loss was $30.8 million, compared to $13.2 million for the nine
months ended December 31, 2021. For the nine months ended December 31, 2022, and
December 31, 2021, our diluted loss per share was $0.12 and $0.07, respectively.



Liquidity and Capital Resources





We broadly define liquidity as our ability to generate sufficient cash, from
internal and external sources, to meet our obligations and commitments. We
believe that, for this purpose, liquidity cannot be considered separately from
capital resources.



Working Capital



We had a deficiency in our working capital of approximately $23.2 million as of
December 31, 2022, and a working capital of approximately $7.4 million as of
March 31, 2022. As of December 31, 2022, our cash and cash equivalents were
$3.1
million.



We have implemented measures to restructure our business operations and reduce
our monthly cash burns and operating loss. Such measures include, and are not
limited to, headcount reduction and elimination of certain overhead and
consulting fees. Based upon the current level of operations and anticipated
investments necessary to sustain/grow our business, we believe that existing
cash balances and anticipated funds from operations will likely be sufficient to
meet our working capital requirements over the next 12 months.



Historical Cash Flows



Historically, our primary sources of cash have been capital transactions
involving the issuance of equity securities and secured and unsecured debt (See
"Recent Issuances of Equity Securities" and "Short-term Borrowings and
Convertible Notes" below) and cash flows from operating activities; and our
primary uses of cash have been for operating activities, capital expenditures,
acquisitions, net cash advances to related parties, and debt repayments in the
ordinary course of our business.



30







The following table summarizes our cash flow activities for the nine months
ended December 31, 2022, compared to the nine months ended December 31, 2021:



                                                    Year Ended December 31,
                                           2022              2021             Change
Net cash used in operating
activities                             $  (8,845,938 )   $ (13,178,848 )   $   4,332,910
Net cash used in investing
activities                               (11,530,898 )     (12,213,306 )         682,408
Net cash provided by financing
activities                                 6,501,659        33,073,607       (26,571,948 )
Impact of currency rate changes in
cash                                         (35,864 )         (45,331 )   

9,467


Net (decrease) increase in cash and
cash equivalents                       $ (13,911,041 )   $   7,636,122     $ (21,547,163 )

Net Cash Used in Operating Activities





For the nine months ended December 31, 2022, net cash used in operating
activities was $8.8 million, compared to net cash used in operating activities
of $13.7 million for the nine months ended December 31, 2021. The $4.3 million
change was due primarily to decline in gross profit, excluding non-cash items,
such as depreciation and amortization, stock-based compensation gain, provision
for obsolete inventory losses, amortization of debt discount, losses on
impairment of investments in unconsolidated entities, a note receivable, and the
gain on extinguishment of debt. In addition, the change in net cash used in
operating activities reflects a change in operating assets and liabilities of
approximately $6.3 million driven by the normal recurring operations of the
business.



Net Cash Used in Investing Activities





For the nine months ended December 31, 2022, net cash used in investing
activities was $11.5 million, compared to $12.2 million for the nine months
ended December 31, 2021. Included in the $11.5 million of net cash outflow was
cash paid for marketable securities of approximately $9.5 million during the
nine months ended December 31, 2022.



Net Cash Provided by Financing Activities

For the nine months ended December 31, 2022, net cash provided by financing activities decreased by $26.6 million, to $6.5 million, compared to $33.1 million for the nine months ended December 31, 2021, primarily due to refinancing of the June 2022 DSSI loan.

Impact of currency rate changes in cash





For the nine months ended December 31, 2022, the impact of currency rate changes
in cash was negative $35,864 compared to negative $45,331 for the nine months
ended December 31, 2021.



Legal Proceedings


The information contained in Note 16, COMMITMENTS AND CONTINGENCIES - Legal Proceedings, of the Notes to the Unaudited Condensed Consolidated Financial Statements located elsewhere in this Quarterly Report is incorporated herein by reference.





Potential Future Acquisitions



The Company, directly and through its subsidiaries, may make strategic
acquisitions and purchases of equity interests in businesses that complement its
business competencies and growth strategy. Such acquisitions and purchases of
equity interests are expected to be funded with cash and cash equivalents, cash
provided by operations, if any, and issuance of equity securities and debt.

Short-term Borrowings and Convertible Notes

Borrowing Under Financing Arrangements (Note Payable)





In May 2020, the Company was granted a loan (the "PPP Loan") by a commercial
bank in the amount of $1.0 million, pursuant to the Paycheck Protection Program
features of the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the
"CARES Act"). The Company's borrowings under the PPP Loan were eligible for loan
forgiveness under the provisions of the CARES Act. In June of 2021, the Company
was formally notified by the lender that the Company's obligations under the
loan had been forgiven effective May 25, 2021. The loan forgiveness applies to
all principal and interest accrued through the loan forgiveness effective date.



31






Convertible Notes from Related Parties

Decentralized Sharing Systems, Inc.





On April 5, 2021, the Company and Decentralized Sharing Systems, Inc. ("DSSI")
which, together with DSS, Inc., is a majority shareholder of the Company,
entered into a Securities Purchase Agreement, pursuant to which the Company
issued: (a) a Convertible Promissory Note in the principal amount of $30.0
million (the "Note") in favor of DSSI, and (b) a detachable Warrant to purchase
up to 150,000,000 shares of the Company's Class A Common Stock, at $0.22 per
share, and DSSI loaned to the Company $30.0 million. Under the terms of the
loan, the Company agreed to pay to DSSI a loan Origination Fee of $3.0 million,
payable in shares of the Company's Class A Common Stock, at the rate of $0.20
per share. The Note bears interest at the annual rate of 8% and matures on April
5, 2024, subject to certain acceleration provisions upon the occurrence of an
Event of Default, as defined in the Note. At any time during the term of the
Note, all or part of the Note, including principal, less unamortized prepaid
interest, if any, plus any accrued interest and other fees was convertible into
shares of the Company's Class A Common Stock at the rate of $0.20 per share, at
the option of the holder.



On June 15, 2022, the Company and DSSI entered into an agreement pursuant to
which the Company issued to DSSI: (a) a two-year Convertible, Advancing
Promissory Note in the principal amount of $27.0 million (the "2022 Note") in
favor of DSSI and (b) a detachable warrant to purchase up to 818,181,819 shares
of the Company's Class A Common Stock at the exercise price of $0.033 per share.
The 2022 Note bears interest at the annual rate of 8% and is due and payable on
demand or, if no demand, on May 1, 2024. At any time during the term of the 2022
Note, all or part of the Note may be converted into up to 818,181,819 shares of
the Company's Class A Common Stock, at the option of the holder. Under the terms
of the agreement, the Company paid to DSSI a loan origination fee of $270,000,
and DSSI surrendered to the Company all DSSI's rights pursuant to the
Convertible Promissory Note in the principal amount of $30.0 million issued by
the Company in April 2021 and the detachable warrant to purchase up to
150,000,000 shares of the Company's Class A Common Stock, at $0.22 per share,
issued concurrently with such $30.0 million note, as discussed in the preceding
paragraph.


American Pacific Bancorp, Inc.





On June 15, 2022, Linden Real Estate Holdings, LLC, a wholly owned subsidiary of
the Company, American Pacific Bancorp, Inc. ("APB"), a subsidiary of DSS, and
the Company entered a Loan Agreement pursuant to which APB loaned the Company
approximately $5.7 million. The loan bears interest at the annual rate of 8%,
matures on December 1, 2024, and is secured by a first mortgage interest on the
Company's Lindon, Utah office building. In connection with this loan, the
Company received net proceeds of $5,522,829 from APB. Heng Fai Ambrose Chan and
Frank D. Heuszel, each a Director of the Company, also serve on the Board of
Directors of APB.



On August 11, 2022, the Company executed a revolving credit promissory note with
APB ("the APB Revolving Note") pursuant to which the Company has access to
advances with a maximum principal balance not to exceed the principal sum of $10
million. The APB Revolving Note is collateralized by the assets of the Company,
and it bears interest at the annual rate of 8% and such interest shall be due
and payable quarterly as it accrues on the outstanding balance. Interest
payments on the loan are due and payable on the last day of each consecutive
third calendar month until the maturity date of August 12, 2024. On December 9,
2022, APB and the Company mutually agreed to limit and/or end any further
commitment by APB to fund or to readvance under the terms of the APB Revolving
Note. As of December 31, 2022, the Company had $6.0 million outstanding under
the APB Revolving Note.



HWH International, Inc.



In October 2017, the Company issued a Convertible Promissory Note in the
principal amount of $50,000 (the "Note") to HWH International, Inc. ("HWH" or
the "Holder"). HWH is affiliated with Heng Fai Ambrose Chan, who in April 2020
became a Director of the Company. The Note is convertible into 333,333 shares of
the Company's Common Stock. Concurrent with issuance of the Note, the Company
issued to HWH a detachable stock warrant to purchase up to an additional 333,333
shares of the Company's Common Stock, at an exercise price of $0.15 per share.
Under the terms of the Note and the detachable stock warrant, the Holder is
entitled to certain financing rights. If the Company enters into more favorable
transactions with a third-party investor, it must notify the Holder and may have
to amend and restate the Note and the detachable stock warrant to be identical.
On August 9, 2022, HWH and the Company executed an agreement to settle the Note
and cancel the related stock warrant for $78,636, which amount represents the
principal plus accrued interest. The Company made the payment to HWH on August
9, 2022.



Capital Requirements



During the nine months ended December 31, 2022, capital expenditures for
property and equipment (consisting of furniture and fixtures, computer equipment
and software, other office equipment and leasehold improvements) in the ordinary
course of our business were $1.4 million which primarily relates to the purchase
of the multi-user license and code for development of a new sales commissions'
platform.



32







Contractual Obligations



There were no material changes to our contractual cash obligations during the
nine months ended December 31, 2022, except for (a) the June 2022 refinancing of
our loan from DSSI (b) the June 2022 financing of our Lindon, Utah office
building, and (c) the August 2022 revolving line of credit with APB, as all
described above.



Off-Balance Sheet Financing Arrangements

As of December 31, 2022, we had no off-balance sheet financing arrangements.





Inflation



Prior to the COVID-19 pandemic, inflation was generally been low in the
geographies where we operate. However, at the time of this Quarterly Report, the
increase in price of consumer goods in the United States has reached a 40-year
high, primarily as a result of higher energy costs, higher housing costs, and
the impact global supply chain disruptions. Please see "Our business and
financial performance could be adversely affected by inflation" contained in
ITEM 1A, - "Risk Factors" in our Annual Report on Form 10-K for the fiscal

year
ended March 31, 2022.


Critical Accounting Estimates





While the Company is not aware of material changes to its critical accounting
estimates or assumptions since March 31, 2022, it is reasonably possible that
estimates made in the Company's unaudited condensed consolidated financial
statements have been, or will be, materially impacted as a result of the
ultimate resolution of the uncertainties associated with the COVID health
crisis. This may include estimates regarding allowance for slow-moving or
obsolete inventory, impairment losses related to long-lived assets, the nature
and timing of satisfaction of performance obligations resulting from contracts
with customers, and the valuation of loss contingencies. Please see Overview -
Continuing Uncertainty Regarding the Recent COVID Pandemic above.



Accounting Changes and Recent Accounting Pronouncements


For discussion of accounting changes and recent accounting pronouncements, see
Note 2 of the Notes to the Unaudited Condensed Consolidated Financial Statements
contained elsewhere in this Quarterly Report.

© Edgar Online, source Glimpses